SCHEMBL4556503

SCHEMBL4556503

COc1ccccc1C(CC(N)=O)C(N)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
HTT P42858 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.48
LMNA P02545 2/20 0.48
KDM4E B2RXH2 1/20 0.48
CYP1A2 P05177 1/20 0.48
CTSD P07339 1/20 0.44
KMT2A Q03164 1/20 0.44
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA12 O43570 1/20 0.43
CA4 P22748 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CA14 Q9ULX7 1/20 0.43
PDE4A P27815 2/20 0.43
PDE4B Q07343 2/20 0.43
PDE4C Q08493 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19920065 0.85 POLB (0.47) POLBL3MBTL1HTTNPSR1SMN1; SMN2
SCHEMBL6657928 0.85 POLB (0.47) POLBL3MBTL1HTTNPSR1SMN1; SMN2
SCHEMBL11073553 0.84 LMNA (0.46) POLBL3MBTL1HTTNPSR1SMN1; SMN2
Hydrochloric Acid SCHEMBL6409959 0.83 POLB (0.46) POLBL3MBTL1HTTNPSR1SMN1; SMN2
SCHEMBL7181205 0.83 POLB (0.46) POLBL3MBTL1HTTNPSR1SMN1; SMN2
SCHEMBL11077027 0.83 POLB (0.66) POLBL3MBTL1HTTNPSR1SMN1; SMN2
SCHEMBL17755257 0.81 POLB (0.51) POLBL3MBTL1HTTNPSR1SMN1; SMN2
SCHEMBL23256418 0.81 EPHX1 (0.58) POLBL3MBTL1HTTNPSR1SMN1; SMN2
SCHEMBL5160804 0.79 PDE4A (0.49) POLBL3MBTL1HTTNPSR1LMNA
SCHEMBL14678302 0.79 L3MBTL1 (0.53) POLBL3MBTL1HTTNPSR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090298781-A1 COMPOUNDS FOR THE INHIBITION OF APOPTOSIS CONSEJO SUPERIOR DE (ES) 2009-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298781-A1 COMPOUNDS FOR THE INHIBITION OF APOPTOSIS BAX, BCL2, CASP3 POLB 2126/4885L3MBTL1 1826/4885HTT 3489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.